{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T06:41:39Z","timestamp":1777185699068,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Italian Health Ministry","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}]},{"name":"Italian Health Ministry","award":["Familia Project 2011-02351489"],"award-info":[{"award-number":["Familia Project 2011-02351489"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Operating Grant"],"award-info":[{"award-number":["Operating Grant"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12881-017-0445-0","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T08:36:33Z","timestamp":1501749393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Large intragenic deletion of CDC73 (exons 4\u201310) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5500-8558","authenticated-orcid":false,"given":"Vito","family":"Guarnieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raewyn M.","family":"Seaberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jean Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Raphael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew Y.","family":"Shuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena","family":"Baorda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orazio","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey N.","family":"Hendy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E. C.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"445_CR1","first-page":"62","volume":"1251","author":"RA DeLellis","year":"2008","unstructured":"DeLellis RA, Mazzalia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med. 2008;1251:62.","journal-title":"Arch Pathol Lab Med"},{"key":"445_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000345675","volume":"41","author":"GN Hendy","year":"2013","unstructured":"Hendy GN, Cole DEC. Genetic defects associated with familial and sporadic hyperparathyroidism. Front Horm Res. 2013;41:149\u201365.","journal-title":"Front Horm Res"},{"key":"445_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12022-008-9050-2","volume":"19","author":"RA DeLellis","year":"2008","unstructured":"DeLellis RA. Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma. Endocr Pathol. 2008;19:221\u20135.","journal-title":"Endocr Pathol"},{"key":"445_CR4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1365-2796.2003.01168.x","volume":"253","author":"JD Chen","year":"2003","unstructured":"Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD, Teh BT. Hyperparathyroidism-jaw tumor syndrome. J Intern Med. 2003;253:634\u201342.","journal-title":"J Intern Med"},{"key":"445_CR5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, H\u00f6\u00f6g A, Heath H 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR. HRPT2 encoding parafibromin is mutated in hyperparathyroidism\u2013jaw tumor syndrome. Nat Gen. 2002;32:676\u201380.","journal-title":"Nat Gen"},{"key":"445_CR6","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1128\/MCB.25.12.5052-5060.2005","volume":"25","author":"A Yart","year":"2005","unstructured":"Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D, Krek W. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol. 2005;25:5052\u201360.","journal-title":"Mol Cell Biol"},{"key":"445_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","volume":"25","author":"O Rozenblatt-Rosen","year":"2005","unstructured":"Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, Resau JH, Meyerson M. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol. 2005;25:612\u201320.","journal-title":"Mol Cell Biol"},{"key":"445_CR8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","volume":"24","author":"GE Woodard","year":"2005","unstructured":"Woodard GE, Lin L, Zhang J-H, Agarwal SK, Marx SJ, Simonds WF. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclinD1\/PRAD1 expression. Oncogene. 2005;24:1272\u20135.","journal-title":"Oncogene"},{"key":"445_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cell.2006.01.053","volume":"125","author":"C Mosimann","year":"2006","unstructured":"Mosimann C, Hausmann G, Basler K. Parafibromin\/hyrax activates Wnt\/Wg target gene transcription bydirect association with beta-catenin\/armadillo. Cell. 2006;125:327\u201341.","journal-title":"Cell"},{"key":"445_CR10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumors. J Med Gen. 2003;40:657\u20133.","journal-title":"J Med Gen"},{"key":"445_CR11","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, V\u00e4lim\u00e4ki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349:1722\u20139.","journal-title":"N Engl J Med"},{"key":"445_CR12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","volume":"35","author":"V Guarnieri","year":"2012","unstructured":"Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D, Baorda F, Maiello E, D'Agruma L, Chiodini I, Clemente C, Minisola S, Romagnoli E, Corbetta S, Viti R, Eller-Vainicher C, Spada A, Iacobellis M, Malavolta N, Carella M, Canaff L, Hendy GN, Cole DE, Scillitani A. CDC73 mutations and parafibromin immunhistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort. Cell Oncol (Dordrecht). 2012;35:411\u201322.","journal-title":"Cell Oncol (Dordrecht)"},{"key":"445_CR13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","volume":"31","author":"PJ Newey","year":"2010","unstructured":"Newey PJ, Bowl MR, Cranston T, Thakker RV. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum Mut. 2010;31:295\u2013307.","journal-title":"Hum Mut"},{"key":"445_CR14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/gcc.20911","volume":"50","author":"A Casc\u00f3n","year":"2011","unstructured":"Casc\u00f3n A, Huarte-Mendicoa CV, Javier Leandro-Garc\u00eda L, Let\u00f3n R, Suela J, Santana A, Costa MB, Comino-M\u00e9ndez I, Landa I, S\u00e1nchez L, Rodr\u00edguez-Antona C, Cigudosa JC, Robledo M. Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family. Genes Chromosomes Cancer. 2011;50:922\u20139.","journal-title":"Genes Chromosomes Cancer"},{"key":"445_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.2011.04184.x","volume":"76","author":"R Domingues","year":"2012","unstructured":"Domingues R, Tomaz RA, Martins C, Nunes C, Bugalho MJ, Cavaco BM. Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism. Clin Endocrinol. 2012;76:33\u20138.","journal-title":"Clin Endocrinol"},{"key":"445_CR16","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","volume":"98","author":"L Bricaire","year":"2013","unstructured":"Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM, Murat A, Caron P, Sadoul JL, Silve C, Chanson P, Barlier A, Clauser E, Porchet N. Groussin L; GTE group. Frequent large germline HRPT2 deletions in a French national cohort of patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2013;98:E403\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR17","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1210\/jc.2014-1481","volume":"99","author":"E Korpi-Hy\u00f6v\u00e4lti","year":"2014","unstructured":"Korpi-Hy\u00f6v\u00e4lti E, Cranston T, Ryh\u00e4nen E, Arola J, Aittom\u00e4ki K, Sane T, Thakker RV, Schalin-J\u00e4ntti C. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma. J Clin Endocrinol Metab. 2014;99:3044\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/cen.12461","volume":"81","author":"J Kong","year":"2014","unstructured":"Kong J, Wang O, Nie M, Shi J, Hu Y, Jiang Y, Li M, Xia W, Meng X, Xing X. Familial isolated primary hyperparathyroidism\/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese. Clin Endocrinol. 2014;81:222\u201330.","journal-title":"Clin Endocrinol"},{"key":"445_CR19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MPH.0000000000000443","volume":"38","author":"JT Davidson","year":"2016","unstructured":"Davidson JT, Lam CG, McGee RB, Bahrami A, Diaz-Thomas A. Parathyroid cancer in the pediatric patient. J Pediatr Hematol Oncol. 2016;38:32\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"445_CR20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","volume":"257","author":"KJ Bradley","year":"2005","unstructured":"Bradley KJ, Hobbs MR, Buley ID, Carpten JD, Cavaco BM, Fares JE, Laidler P, Manek S, Robbins CM, Salti IS, Thompson NW, Jackson CE, Thakker RV. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med. 2005;257:18\u201326.","journal-title":"J Intern Med"},{"key":"445_CR21","doi-asserted-by":"crossref","first-page":"e82292","DOI":"10.1371\/journal.pone.0082292","volume":"8","author":"V Pazienza","year":"2013","unstructured":"Pazienza V, la Torre A, Baorda F, Alfarano M, Chetta M, Muscarella LA, Battista C, Copetti M, Kotzot D, Kapelari K, Al-Abdulrazzaq D, Perlman K, Sochett E, Cole DE, Pellegrini F, Canaff L, Hendy GN, D'Agruma L, Zelante L, Carella M, Scillitani A, Guarnieri V. Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene. PLoS One. 2013;8:e82292.","journal-title":"PLoS One"},{"key":"445_CR22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","volume":"64","author":"KJ Bradley","year":"2006","unstructured":"Bradley KJ, Cavaco BM, Bowl MR, Harding B, Cranston T, Fratter C, Besser GM, Concei\u00e7\u00e3o Pereira M, Davie MW, Dudley N, Leite V, Sadler GP, Seller A, Thakker RV. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumors. Clin Endocrinol. 2006;64:299\u2013306.","journal-title":"Clin Endocrinol"},{"key":"445_CR23","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/000348940711601210","volume":"116","author":"KM Hewitt","year":"2007","unstructured":"Hewitt KM, Sharma PK, Samowitz W, Hobbs M. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma. Ann Otol Rhinol Laryngol. 2007;116:928\u201333.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"445_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1677\/ERC-09-0291","volume":"18","author":"MA Hahn","year":"2010","unstructured":"Hahn MA, Howell VM, Gill AJ, Clarkson A, Weaire-Buchanan G, Robinson BG, Delbridge L, Gimm O, Schmitt WD, Teh BT, Marsh DJ. CDC73\/HRPT2 CpG island hypermethylation and mutation of 5\u2032-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocr Relat Cancer. 2010;18:273\u201382.","journal-title":"Endocr Relat Cancer"},{"key":"445_CR25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1074\/jbc.M113.483255","volume":"289","author":"MI Rather","year":"2014","unstructured":"Rather MI, Swamy S, Gopinath KS, Kumar A. Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II inhibitor, by Wilms tumor 1 protein (WT1) promotes cell proliferation. Implication for cancer therapeutics. J Biol Chem. 2014;289:968\u201376.","journal-title":"J Biol Chem"},{"key":"445_CR26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1074\/jbc.M112.425736","volume":"288","author":"MI Rather","year":"2013","unstructured":"Rather MI, Nagashri MN, Swamy SS, Gopinath KS, Kumar A. Oncogenic microRNA-155 downregulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation. Implications for cancer therapeutics. J Biol Chem. 2013;288:608\u201318.","journal-title":"J Biol Chem"},{"key":"445_CR27","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2005-1239","volume":"91","author":"V Guarnieri","year":"2006","unstructured":"Guarnieri V, Scillitani A, Muscarella LA, Battista C, Bonfitto N, Bisceglia M, Minisola S, Mascia ML, D'Agruma L, Cole DE. Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance. J Clin Endocrinol Metab. 2006;91:2827\u201332.","journal-title":"J Clin Endocrinol Metab"},{"key":"445_CR28","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1359\/jbmr.060702","volume":"21","author":"TG Kelly","year":"2006","unstructured":"Kelly TG, Shattuck TM, Reyes-Mugica M, Stewart AF, Simonds WF, Udelsman R, Arnold A, Carpenter TO. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res. 2006;21:1666\u201371.","journal-title":"J Bone Miner Res"},{"key":"445_CR29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.surg.2007.12.012","volume":"143","author":"MS Sarquis","year":"2008","unstructured":"Sarquis MS, Silveira LG, Pimenta FJ, Dias EP, Teh BT, Friedman E, Gomez RS, Tavares GC, Eng C, De Marco L. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery. 2008;143:630\u20134.","journal-title":"Surgery"},{"key":"445_CR30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1590\/S0004-27302008000800003","volume":"143","author":"LG Silveira","year":"2008","unstructured":"Silveira LG, Dias EP, Marinho BC, Gomez RS, De Marco L, Sarquis MS. HRPT2-related familial isolated hyperparathyroidism: could molecular studies direct the surgical approach? Arq Bras Endocrinol Metabol. 2008;143:1211\u201320.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"445_CR31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.surg.2008.08.008","volume":"144","author":"V Guarnieri","year":"2008","unstructured":"Guarnieri V, Bisceglia M, Bonfitto N, Cetani F, Marcocci C, Minisola S, Battista C, Chiodini I, Cole DE, Scillitani A. Re: familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery. 2008;144:839\u201340.","journal-title":"Surgery"},{"key":"445_CR32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.surg.2008.06.027","volume":"145","author":"M Iacobone","year":"2009","unstructured":"Iacobone M, Barzon L, Porzionato A, Masi G, Macchi V, Viel G, Favia G. The extent of parathyroidectomy for HRPT2-related hyperparathyroidism. Surgery. 2009;145:250\u20131.","journal-title":"Surgery"},{"key":"445_CR33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.surg.2014.08.004","volume":"156","author":"A Mehta","year":"2014","unstructured":"Mehta A, Patel D, Rosenberg A, Baufragech M, Ellis RJ, Nilubol N, Quezado MM, Marx SJ, Simonds WF, Kebebew E. Hyperparathyroidism-jaw tumor syndrome: results of operative management. Surgery. 2014;156:1315\u201324.","journal-title":"Surgery"}],"updated-by":[{"DOI":"10.1186\/s12881-017-0459-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T00:00:00Z","timestamp":1505260800000}}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-017-0445-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T04:08:40Z","timestamp":1505966920000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-017-0445-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1186\/s12881-017-0445-0","relation":{"erratum":[{"id-type":"doi","id":"10.1186\/s12881-017-0459-7","asserted-by":"object"}]},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]},"article-number":"83"}}